Last Updated: 21/11/2024
Medicines for Malaria Venture: Drug Discovery, Translation, and Development
Objectives
This project aims to further drug discovery and development aimed at delivering innovative medicines required to enhance the clinical case management of malaria in malaria-endemic countries. Specific objectives include:
- Portfolio investment to support the discovery and development of new drugs to treat and prevent malaria.
- Development of a new single-encounter radical cure (SERC).
- Development of a new seasonal malaria chemoprevention / mass drug administration (SMC/MDA) regimen.
- New Plasmodium falciparum (Pf) drug candidates.
- New Plasmodium vivax (Pv) non-hemolytic drug candidates.
Principal Institution
Principal Investigators / Focal Persons
External reference
Date
Dec 2018 — Jan 2025
Total Project Funding
$180M
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-007155 (Formerly OPP1191677)
Country / Project Site(s)


